Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Free Cash Flow (2023 - 2025)

Camp4 Therapeutics' Free Cash Flow history spans 3 years, with the latest figure at $6.3 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 154.73% year-over-year to $6.3 million; the TTM value through Dec 2025 reached -$29.8 million, up 35.22%, while the annual FY2025 figure was -$29.8 million, 35.22% up from the prior year.
  • Free Cash Flow for Q4 2025 was $6.3 million at Camp4 Therapeutics, up from -$11.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $6.3 million in Q4 2025 and bottomed at -$14.6 million in Q1 2025.
  • The 3-year median for Free Cash Flow is -$11.3 million (2024), against an average of -$9.7 million.
  • The largest YoY upside for Free Cash Flow was 154.73% in 2025 against a maximum downside of 29.09% in 2025.
  • A 3-year view of Free Cash Flow shows it stood at -$11.7 million in 2023, then increased by 1.6% to -$11.6 million in 2024, then surged by 154.73% to $6.3 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Free Cash Flow are $6.3 million (Q4 2025), -$11.2 million (Q3 2025), and -$10.3 million (Q2 2025).